Feasibility of a Pilot Program for COVID-19 Convalescent Plasma Collection in Wuhan, China.

CONCLUSION: Based on a feasibility study of a pilot CCP program in Wuhan China, we demonstrated the success and feasibility of CCP collection. In addition, all of the CCP units collected had a titer of ≥ 1:160 for S-RBD-specific IgG antibody, which met the CCP quality control requirements based on the Chinese national guidelines for CCP. This article is protected by copyright. All rights reserved. PMID: 32491199 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/32491199?dopt=Abstract

Source: Transfusion - June 2, 2020 Category: Hematology Authors: Li L, Yang R, Wang J, Lv Q, Ren M, Zhao L, Chen H, Xu H, Xie S, Xie J, Lin H, Li W, Fang P, Gong L, Gao X, Wang L, Wu Y, Liu Z Tags: Transfusion Source Type: research